Is Bugleweed Good for Graves’ Disease? (What the Research Says)

Key takeaways

• We have very little high-quality human research on bugleweed in Graves’ disease.
• However, laboratory, animal, and early-stage studies suggest that bugleweed may have thyroid-suppressing and immune-modulating effects.
• This means it is scientifically plausible that bugleweed could help some people with hyperthyroidism or Graves’ disease.
• Robust clinical trials are still needed before we can confirm whether bugleweed is effective in humans.

What is bugleweed (Lycopus)?

Bugleweed (Lycopus species) is a herb traditionally used for:

• overactive thyroid symptoms
• palpitations
• anxiety

Because Graves’ disease causes hyperthyroidism, bugleweed is often discussed in natural or alternative approaches to Graves’ disease.

Bugleweed taken for Graves’ disease (evidence overview)

One of the few papers that directly looks at bugleweed in Graves’ disease is a small case report published in the Journal of the Endocrine Society (2021). This report describes two patients with Graves’ disease who improved after taking herbal products containing bugleweed and lemon balm.

Key limitation: This approach comes from an individual case report, not a standardised or proven treatment protocol.

Case 1: Patient treated with herbal therapy (bugleweed and lemon balm)

A 64-year-old woman was diagnosed with Graves’ disease following routine blood tests. Her TSH was very low (0.01), her Free T3 was slightly elevated, and her Free T4 was within the normal range. She also had raised thyroid-stimulating antibodies (TSI), confirming the diagnosis. She then began taking a herbal product containing bugleweed and lemon balm.

Over the following months:

• Thyroid hormone levels returned to normal
• Antibody levels normalised
• Stable without needing standard anti-thyroid medication

Case 2: Patient transitioned from antithyroid medication to herbal therapy

A 46-year-old woman was diagnosed with Graves’ disease after presenting with symptoms including palpitations, jitteriness, and thyroid eye disease. She was initially treated with Methimazole, but had to stop due to liver side effects. She then began taking a herbal tincture containing bugleweed and lemon balm.

After this:

• Thyroid levels stabilised
• Symptoms improved
• Antibody levels gradually returned to normal
• No further conventional treatment required

Possible explanations

The authors suggest that bugleweed and lemon balm may have anti-thyroid effects.

Laboratory and animal studies show these herbs may:

• reduce thyroid hormone production
• interfere with stimulation from Graves’ antibodies

However, these findings have not been confirmed in robust clinical trials.

Important limitations

This evidence is very limited. Only two patients were studied, there was no control group, and causation cannot be established. Other factors may explain the results, including natural remission, prior medication, or the use of multiple herbs. The effect of bugleweed alone is therefore unclear.

What this study actually means

This study shows that improvement is possible in individual cases, but it does not prove that bugleweed can reliably treat or reverse Graves’ disease.

Larger, well-designed clinical trials would be needed before any firm conclusions could be made.

Why are there no randomised controlled trials (RCTs) on bugleweed?

There are several reasons why high-quality clinical trials on bugleweed remain limited. Large clinical trials are expensive and often focus on treatments with strong commercial incentives. Because herbs such as bugleweed are difficult to patent, less research funding may be available compared with pharmaceutical drugs. As a result, the absence of large clinical trials does not necessarily prove that bugleweed is ineffective – only that robust human research is still lacking.

In addition, bugleweed is difficult to standardise. It can vary in species, preparation, and potency, which makes it harder to design consistent and comparable studies.

There are also ethical and practical limitations to conducting bugleweed trials in Graves’ disease. Graves’ disease can become serious if left untreated, with risks including heart rhythm problems, bone loss, and thyroid storm. This makes it difficult for researchers to ethically test bugleweed as a stand-alone replacement for established medical treatment in large clinical trials. While studies could theoretically include people unwilling to take standard medication, such trials would still require careful monitoring and substantial funding.

What does the evidence we have actually show?

Human studies
– Only small case reports exist
– No randomised controlled trials
– No consistent evidence of remission or antibody reduction

Animal and laboratory studies
– Suggest possible anti-thyroid effects
– Mechanisms include reduced hormone production and receptor interaction

What this means
– Biological plausibility exists
– But clinical effectiveness is unproven

Why might bugleweed help?

1. Possible effect on thyroid hormones

Some compounds in bugleweed may slightly reduce thyroid hormone production and release. However, these effects are based on laboratory studies and traditional use, and have not been demonstrated in people with Graves’ disease.

2. Anti-inflammatory effects

Bugleweed may contain antioxidant and anti-inflammatory compounds. Because Graves’ disease is an autoimmune condition, this may appear promising. However, there is no good evidence that bugleweed reduces Graves’-specific antibodies or changes the course of the disease.

Can bugleweed treat or reverse Graves’ disease naturally?

There is currently no good clinical evidence that bugleweed can treat, reverse, or put Graves’ disease into remission. No high-quality human studies (such as randomized controlled trials) have shown that bugleweed improves Graves’-specific antibodies or remission rates.

Remission in Graves’ disease has mainly been studied using established treatments such as antithyroid medication, radioactive iodine, and surgery. Bugleweed should not be used as a replacement for standard medical care.

Is bugleweed safe?

There is limited safety data on the use of bugleweed in people with Graves’ disease. Potential concerns include variable product quality, inconsistent dosing, contamination risk, and uncertainty around the active compounds.

Bugleweed may also interact with medications such as antithyroid drugs (e.g. methimazole or carbimazole) and beta blockers. These interactions could mask symptoms, interfere with treatment, or affect thyroid blood test results.

Should you take bugleweed for Graves’ disease?

Based on current evidence, bugleweed is not recommended as a treatment for Graves’ disease.

– It has not been proven in clinical trials
– Effects reported to date are inconsistent and unpredictable
– It may interact with medication
– It does not address the underlying autoimmune process (although current Graves’ medications also mainly work by controlling excess thyroid hormone production).

If used at all, it should be under medical supervision and not to replace standard treatment.

Bugleweed vs proven treatments for Graves’ disease

My take

Bugleweed is an interesting example of how some natural compounds may show promising biological effects long before robust human research catches up.

At the moment, the science around bugleweed and Graves’ disease is still too limited to draw strong conclusions, but it is arguably an area that deserves more scientific attention.

Conclusion

There is currently insufficient high-quality human evidence to confirm whether bugleweed improves Graves’ disease or helps induce remission. More robust Graves’-specific clinical trials are needed.

Because Graves’ disease can become serious if poorly controlled, bugleweed should only be used with appropriate medical supervision and monitoring. This may include heart rate, TSH, free T4, free T3, and thyroid antibodies (TRAb, if available).

For a full breakdown of approaches that have actually been studied, see my guide on diet and lifestyle approaches for Graves’ disease.

FAQs